CVS Health said it is now accepting TrumpRx discount cards at its roughly 9,000 pharmacies nationwide, giving eligible patients access to manufacturer-backed savings on select medications.
The company said its 27,000 pharmacists will guide customers in applying the discounts and support related programs, including NovoCare enrollment and reduced pricing on fertility medications through the TrumpRx Fertility initiative. The move gives the newly launched TrumpRx platform national visibility inside one of the country's largest retail pharmacy networks.
TrumpRx was created to provide consumers with direct access to manufacturer-negotiated drug discounts, with the mission of making prescription medications more affordable and transparent, particularly for patients paying out of pocket. Rather than selling medications, the platform aggregates discounts and provides price referrals, connecting patients to participating pharmacies.
First announced in late 2025, TrumpRx combines direct-to-consumer access with "most-favored-nation" (MFN) pricing, requiring manufacturers to match or beat the lowest prices paid in comparable wealthy countries. The platform officially launched this month with roughly 43 medications, focusing on cash-pay options that primarily benefit uninsured or out-of-network patients.
Most drugs require patients to print manufacturer discount cards and redeem them via the GoodRx network. At this time, TrumpRx discounted pricing is only available for cash-paying patients and generally cannot be combined with employer-sponsored or commercial insurance.
TrumpRx has secured partnerships with manufacturers such as Pfizer, offering drugs including Eucrisa and Xeljanz at MFN-aligned discounts, and AstraZeneca, which committed to discounted offerings and U.S. investments. Mark Cuban's Cost Plus Drugs, an online pharmacy, announced it would join the effort by providing API access for real-time pricing data, increasing transparency and potentially lowering consumer costs.
Initial listings highlight cash-pay discounts across several therapeutic areas. Injectable Wegovy pens are about $199 for the first two fills, while the Wegovy pill starts around $149 per month; Ozempic is $199 for the first two fills; fertility drugs include Gonal‑F at $168 per pen and Cetrotide at $22.50. Other examples include Eucrisa at $158.48, Chantix at $106.20 and insulin lispro at $25.
The White House has said it expects to add additional drugs and partner with more manufacturers in the coming months, potentially broadening the range of discounted offerings.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.